cbdMD, Inc. (YCBD) |
| 0.6476 -0.01 (-1.54%) 07-15 10:27 |
| Open: | 0.6632 |
| High: | 0.6699 |
| Low: | 0.6254 |
| Volume: | 189,175 |
| Market Cap: | 7(M) |
| PE Ratio: | -1.59 |
| Exchange: | New York Stock Exchange American |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.82 |
| Resistance 1: | 0.74 |
| Pivot price: | 0.71 |
| Support 1: | 0.62 |
| Support 2: | 0.52 |
| 52w High: | 2.56 |
| 52w Low: | 0.47 |
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Tue, 14 Jul 2026
Oasis' zero-proof hemp-derived drink reaches South Carolina liquor stores - Stock Titan
Thu, 09 Jul 2026
cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation - Morningstar
Tue, 07 Jul 2026
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination - Yahoo Finance
Thu, 25 Jun 2026
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products - Morningstar
Tue, 16 Jun 2026
cbdMD Appoints Wade Brown Chief Marketing Officer - Morningstar
Thu, 14 May 2026
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |